Short Interest in Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Decreases By 54.7%

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 274,900 shares, a decrease of 54.7% from the September 30th total of 606,600 shares. Approximately 1.8% of the shares of the company are short sold. Based on an average daily trading volume, of 437,400 shares, the days-to-cover ratio is currently 0.6 days.

Novo Integrated Sciences Price Performance

NVOS stock remained flat at $0.22 during trading on Friday. The company had a trading volume of 462,921 shares, compared to its average volume of 2,593,436. Novo Integrated Sciences has a 52 week low of $0.20 and a 52 week high of $3.45. The stock’s 50-day moving average is $0.29 and its 200-day moving average is $0.52. The company has a current ratio of 0.27, a quick ratio of 0.22 and a debt-to-equity ratio of 0.01.

Novo Integrated Sciences Company Profile

Novo Integrated Sciences, Inc, together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women’s pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services.